Is there a role for transplant if not used upfront or a second transplant at first relapse?

Is there a role for transplant if not used upfront or a second transplant at first relapse?
Should MGUS be treated?
What is the role of genomics at relapse?
Should an individual diagnosed with MGUS see a specialist?
With so many options available, at what point should a patient consider getting a second opinion?
What should individuals diagnosed with MGUS and smoldering multiple myeloma know about amyloidosis?
How do you decide on an appropriate treatment at relapse with so many to choose from?
What does it mean to be triple class refractory?
What is whole genome sequencing? How has whole-genome sequencing been used to identify progressive versus stable myeloma precursor conditions as two distinct entities?
What is the role of supportive care throughout relapsed and refractory myeloma management?
Should someone diagnosed with smoldering multiple myeloma (SMM) see a myeloma specialist?